Aspira Women's Health Inc. (AWHL)

↓ Download CSV

CIK 0000926617 · OTC · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Aspira Women's Health Inc. reported revenue of $343.0K, up 8475.0% from the prior year. The company ran a net loss, with a net margin of -3725.9% and a gross margin of 1724.5%. It held $5.46M in total assets against $12.39M in total liabilities.

Key ratios (FY2025)

1724.5%
Gross margin
-2307.0%
Operating margin
-3725.9%
Net margin
+8475.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$343.0K$4.0K$87.00M$8.18M$6.81M$4.65M$4.54M$3.05M$3.12M$2.64M
Cost of Revenue$3.30M$3.70M$3.89M$3.86M$3.75M$3.42M$3.34M$3.14M$2.91M$2.70M
Gross Profit$5.92M$5.48M$5.26M$4.32M$3.06M$1.24M$1.20M-$89.0K$207.0K-$56.0K
Operating Income-$7.91M-$16.28M-$18.85M-$31.14M-$32.59M-$17.98M-$15.28M-$11.33M-$10.44M-$14.95M
Net Income-$12.78M-$13.09M-$16.69M-$29.89M-$31.66M-$17.91M-$15.24M-$11.37M-$10.50M-$14.97M
EPS (Diluted)$-0.37$-0.93$-1.81$-3.85$-4.27$-0.18$-0.18$-0.16$-0.20$-0.29
Total Assets$5.46M$5.49M$6.26M$17.37M$41.08M$19.61M$13.83M$11.41M$7.50M$8.02M
Total Liabilities$12.39M$8.05M$8.63M$10.39M$10.91M$9.89M$5.09M$4.26M$4.09M$4.26M
Shareholders' Equity-$6.93M-$2.56M-$2.37M$6.98M$30.17M$9.72M$8.74M$7.15M$3.41M$3.76M
Cash & Equivalents$1.75M$1.77M$2.60M$13.31M$37.18M$16.63M$5.54M$5.24M
Operating Cash Flow-$7.03M-$12.11M-$15.89M-$31.07M-$27.39M-$14.73M-$12.96M-$9.37M-$8.13M
Capital Expenditures$16.0K$37.0K$24.0K$232.0K$184.0K$490.0K$133.0K$113.0K$60.0K$1.26M
Shares Outstanding43.48M17.41M10.65M8.31M7.48M104.62M97.29M75.50M60.04M52.33M